Bloomberg reports, that according to people familiar with the situation, Novartis and Pfizer won’t bid for Onyx Pharmaceuticals, the maker of cancer drugs, leaving Amgen Inc. with only one possible rival bidder remaining.Honestly I still don't believe that Pfizer was ever interested in Onyx acquisition, Pfizer needs Onyx like a hole in the head. There's no sense in buying this particular firm for Pfizer, as I wrote earlier. Companies decline to comment, so I'd say it's just some made up stuff from media. News agencies made such a great deal out of Onyx bids, just wondering... http://www.bloomberg.com/news/2013-08-13/novartis-is-said-to-be-out-of-bidding-for-onyx.html